Healthcare utilization in adults with opioid dependence receiving extended release naltrexone compared to treatment as usual.

William E Soares,Donna Wilson,Niels Rathlev,Joshua D Lee,Michael Gordon,Edward V Nunes,Charles P O'Brien,Peter D Friedmann

Journal of Substance Abuse Treatment（2018）

引用 9|浏览12

暂无评分

摘要

•Extended release naltrexone (XR-NTX) reduces opioid use and cravings.•No significant difference in healthcare utilization rates was found for XR-NTX.•Concerns regarding healthcare utilization should not preclude XR-NTX use.

查看译文

关键词

XR-NTX,TAU,OUD

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要